HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naomi Shimizu Selected Research

Hodgkin Disease (Hodgkin's Disease)

8/2022Urothelial Carcinoma With Pulmonary Tumor Thrombotic Microangiopathy After Chemotherapy for Hodgkin Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naomi Shimizu Research Topics

Disease

10Neoplasms (Cancer)
08/2022 - 03/2011
5Carcinoma (Carcinomatosis)
08/2022 - 03/2018
4POEMS Syndrome (Syndrome, POEMS)
10/2018 - 08/2008
4Leukemia
04/2014 - 02/2012
4Multiple Myeloma
02/2014 - 11/2007
3Atherosclerosis
07/2022 - 12/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 10/2006
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2017 - 10/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
11/2023 - 10/2014
2Morbid Obesity
01/2023 - 01/2021
2Lymphoma (Lymphomas)
07/2022 - 08/2017
2Type 2 Diabetes Mellitus (MODY)
10/2021 - 07/2019
2Sepsis (Septicemia)
10/2021 - 12/2014
2Body Weight (Weight, Body)
10/2021 - 01/2021
2Wilms Tumor (Wilm's Tumor)
11/2020 - 01/2016
2Arteriosclerosis
08/2020 - 08/2017
2Lung Neoplasms (Lung Cancer)
01/2020 - 02/2009
2Hypertension (High Blood Pressure)
08/2017 - 02/2012
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2014 - 02/2012
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2014 - 01/2007
2Crush Injuries
11/2011 - 08/2009
1Insulin Resistance
01/2023
1Pathologic Complete Response
08/2022
1Thrombotic Microangiopathies
08/2022
1Heart Failure
08/2022
1Hodgkin Disease (Hodgkin's Disease)
08/2022
1Ovarian Epithelial Carcinoma
06/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Carcinogenesis
01/2022
1Bacterial Infections (Bacterial Infection)
10/2021
1Albuminuria
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Pancytopenia
11/2020
1Hydrocephalus (Hydrocephaly)
01/2019
1Subependymal Glioma (Subependymoma)
01/2019
1Brain Neoplasms (Brain Tumor)
01/2019
1Urogenital Neoplasms
01/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Pneumoperitoneum
01/2019
1Glioblastoma (Glioblastoma Multiforme)
11/2018
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2018
1Endometriosis
03/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2018
1Inappropriate ADH Syndrome (SIADH)
12/2017
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2017

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
10/2021 - 10/2013
3Rituximab (Mabthera)FDA Link
11/2023 - 08/2017
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2022 - 12/2009
3Semaphorin-3AIBA
09/2015 - 08/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 08/2017
2Prednisolone (Predate)FDA LinkGeneric
07/2022 - 08/2017
2Vincristine (Oncovin)FDA LinkGeneric
07/2022 - 08/2017
2Azacitidine (5 Azacytidine)FDA Link
11/2020 - 04/2013
2CytokinesIBA
01/2018 - 04/2016
2Messenger RNA (mRNA)IBA
01/2018 - 04/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2017 - 12/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 08/2008
2Proteins (Proteins, Gene)FDA Link
04/2016 - 04/2013
2Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2014 - 01/2014
2Urokinase Plasminogen Activator ReceptorsIBA
03/2014 - 04/2013
1Estrogens (Estrogen)FDA Link
11/2023
1Prorenin ReceptorIBA
01/2023
1von Willebrand FactorIBA
07/2022
1Phosphates (Orthophosphate)IBA
06/2022
1RNA Splicing FactorsIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1RNA Helicases (RNA Helicase)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1EnzymesIBA
10/2021
1AlbuminsIBA
01/2021
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
11/2020
1Indicators and Reagents (Reagents)IBA
08/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Eicosapentaenoic AcidIBA
07/2019
1BezafibrateIBA
07/2019
1Fibric Acids (Fibrates)IBA
07/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2019
1Bevacizumab (Avastin)FDA Link
01/2019
1monooxyethylene trimethylolpropane tristearate (MTTS)IBA
01/2019
1Lysine (L-Lysine)FDA Link
11/2018
1Sirtuin 2IBA
11/2018
1Inosine Triphosphate (ITP)IBA
04/2018
1Thrombopoietin ReceptorsIBA
04/2018
1SteroidsIBA
04/2018
1Cell-Free Nucleic AcidsIBA
03/2018
1OxysterolsIBA
01/2018
1Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
01/2018
17-ketocholesterolIBA
01/2018
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018
1Vasopressins (Vasopressin)IBA
12/2017

Therapy/Procedure

11Therapeutics
11/2023 - 02/2009
10Drug Therapy (Chemotherapy)
08/2022 - 02/2012
5Stem Cell Transplantation
10/2018 - 12/2009
2Bariatric Surgery
10/2021 - 01/2021
1Radiotherapy
01/2022
1Glycemic Control
10/2021
1Gastrectomy
01/2021
1Ventriculoperitoneal Shunt
01/2019
1Molecular Targeted Therapy
01/2019